FDA approves updated COVID boosters, but narrows use
14 September, 2025
RNA drug from Regeneron, Alnylam succeeds in rare autoimmune disease trial
14 September, 2025
Lilly to submit obesity pill after hitting goal in third late-stage trial
14 September, 2025
Drugs from China are reshaping biotech. Track the licensing deals here.
14 September, 2025
AbbVie wagers more than $1B on Gilgamesh’s psychedelic drug
14 September, 2025
FDA suspends license for Valneva’s chikungunya shot
14 September, 2025
Royalty Pharma buys BeOne stake in Amgen lung cancer drug sales
14 September, 2025
FDA cancels adcomm on Biohaven drug; Catalent lays off staff
14 September, 2025
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago